# To Evaluate the Effect of Inhaled Medication Together With Exercise and Activity Training on Exercise Capacity and Daily Activities in Patients With Chronic Lung Disease With Obstruction of Airways

> **NCT02085161** · PHASE3 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 304 (actual)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive

## Interventions

- **DRUG:** placebo to tiotropium + olodaterol
- **DRUG:** tiotropium+olodaterol
- **DRUG:** tiotropium +olodaterol
- **DRUG:** tiotropium

## Key facts

- **NCT ID:** NCT02085161
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2015-08
- **Final completion:** 2015-10
- **Target enrollment:** 304 (ACTUAL)
- **Last updated:** 2017-01-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02085161

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02085161, "To Evaluate the Effect of Inhaled Medication Together With Exercise and Activity Training on Exercise Capacity and Daily Activities in Patients With Chronic Lung Disease With Obstruction of Airways". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02085161. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*